Keyword
SGLT2 inhibitor - Selective sodium-glucose transporter-2 inhibitor.
Explore 1 research publication tagged with this keyword
1Publications
4Authors
1Years
Publications Tagged with "SGLT2 inhibitor - Selective sodium-glucose transporter-2 inhibitor."
1 publication found
2025
1 publicationDapagliflozin Induced Severe Pruritis – A Rare Adverse Drug Reaction
Dr.
Namitha Rachel Biji et al.
10/1/2025
ABSTRACTDapagliflozin is an SGLT2 inhibitor that is used to treat type 2 diabetes, as well as those with heart failure and chronic renal disease. We report a case report of a 57-year-old male diabetic who presented with severe pruritis which was later found to be due to dapagliflozin and was totally subsided after discontinuing dapagliflozin. Keyword: SGLT2 inhibitor - Selective sodium-glucose transporter-2 inhibitor.
Keyword Statistics
Total Publications:1
Years Active:1
Latest Publication:2025
Contributing Authors:4
Related Keywords